Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2012 (2012), Article ID 523246, 5 pages
http://dx.doi.org/10.1155/2012/523246
Review Article

PTH Assays: Understanding What We Have and Forecasting What We Will Have

Division of Endocrinology, Escola Paulista de Medicina, UNIFESP, 20266 São Paulo, SP, Brazil

Received 22 November 2011; Accepted 6 February 2012

Academic Editor: Roman Lorenc

Copyright © 2012 Jose Gilberto H. Vieira. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Silverman and R. S. Yalow, “Heterogeneity of parathyroid hormone. Clinical and physiologic implications,” Journal of Clinical Investigation, vol. 52, no. 8, pp. 1958–1971, 1973. View at Google Scholar · View at Scopus
  2. J. F. Habener, B. Kemper, and J. T. Potts, “Calcium dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores,” Endocrinology, vol. 97, no. 2, pp. 431–441, 1975. View at Google Scholar · View at Scopus
  3. J. G. H. Vieira, I. S. Kunii, M. N. Ohe, and A. B. Carvalho, “Heterogeneity of carboxyl-terminal parathyroid hormone circulating forms in patients with hyperparathyroidism due to end stage renal disease,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 9, pp. 1074–1078, 2009. View at Google Scholar · View at Scopus
  4. P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Jüppner, and F. R. Bringhurst, “Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells,” Endocrinology, vol. 142, no. 2, pp. 916–925, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Divieti, M. R. John, H. Jüppner, and F. R. Bringhurst, “Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor,” Endocrinology, vol. 143, no. 1, pp. 171–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Divieti, A. I. Geller, G. Suliman, H. Jüppner, and F. R. Bringhurst, “Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity,” Endocrinology, vol. 146, no. 4, pp. 1863–1870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Berson, R. S. Yalow, G. D. Aurbach, and J. T. Potts Jr., “Immunoassay of bovine and human parathyroid hormone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 49, pp. 613–616, 1963. View at Google Scholar
  8. E. Reiss, J. M. Canterbury, and R. H. Egdahl, “Experience with a radioimmunoassay of parathyroid hormone in human sera,” Transactions of the Association of American Physicians, vol. 81, pp. 104–115, 1968. View at Google Scholar · View at Scopus
  9. C. D. Arnaud, H. S. Tsao, and T. Littledike, “Radioimmunoassay of human parathyroid hormone in serum,” Journal of Clinical Investigation, vol. 50, no. 1, pp. 21–34, 1971. View at Google Scholar · View at Scopus
  10. C. M. Brandão, T. S. Kasamatsu, M. A. Oliveira, and J. G. Vieira, “Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism,” Brazilian Journal of Medical and Biological Research, vol. 22, no. 8, pp. 963–965, 1989. View at Google Scholar · View at Scopus
  11. M. T. Zanella, M. C. Silva, R. B. Peres, S. R. Ferreira, S. A. Draibe, and J. G. Vieira, “Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure,” Brazilian Journal of Medical and Biological Research, vol. 23, no. 3-4, pp. 235–243, 1990. View at Google Scholar · View at Scopus
  12. J. T. Potts Jr., G. W. Tregear, H. T. Keutmann et al., “Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 1, pp. 63–67, 1971. View at Google Scholar · View at Scopus
  13. C. Desplan, A. Jullienne, M. S. Moukhtar, and G. Milhaud, “Sensitive assay for biologically active fragment of human parathyroid hormone,” The Lancet, vol. 2, no. 8030, pp. 198–199, 1977. View at Google Scholar · View at Scopus
  14. T. J. Visser, C. J. Buurman, and J. C. Birkenhager, “Immunological studies on parathyroid hormone: characterization of antisera against synthetic 1-34 human parathyroid hormone and evidence that position 30 in human parathyroid hormone is aspartic acid,” Journal of Endocrinology, vol. 74, no. 3, pp. 461–466, 1977. View at Google Scholar · View at Scopus
  15. M. J. Atkinson, H. Jüpnner, B. Niepel, M. Casaretto, H. Zahn, and R.D. Hesch, “Characterization of binding sites of antiparathyroid hormone antisera using synthetic parathyroid hormone peptides,” Journal of Immunoassay, vol. 3, pp. 31–51, 1982. View at Google Scholar
  16. J. G. H. Vieira, M. A. D. Oliveira, and R. M. B. Maciel, “Development of an homologous radioimmunoassay for the synthetic amino terminal (1-34) fragment of human parathyroid hormone using egg yolk-obtained antibodies,” Journal of Immunoassay, vol. 7, no. 1-2, pp. 57–72, 1986. View at Google Scholar · View at Scopus
  17. J. G. Vieira, M. A. Oliveira, J. T. Hidal, E. M. Russo, and A. R. Chacra, “Critical analysis of 2 segment-specific radioimmunoassays for the measurement of parathyroid hormones in the diagnosis of primary hyperparathyroidism,” Revista da Associacao Medica Brasileira, vol. 34, no. 3, pp. 79–83, 1988. View at Google Scholar · View at Scopus
  18. C. M. Brandão, T. S. Kasamatsu, M. A. Oliveira, and J. G. Vieira, “Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism,” Brazilian Journal of Medical and Biological Research, vol. 22, no. 8, pp. 963–965, 1989. View at Google Scholar · View at Scopus
  19. S. R. Nussbaum, R. J. Zahradnik, J. R. Lavigne et al., “Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia,” Clinical Chemistry, vol. 33, no. 8, pp. 1364–1367, 1987. View at Google Scholar · View at Scopus
  20. J. G. Vieira, S. K. Nishida, T. S. Kasamatsu, E. C. Amarante, and I. S. Kunii, “Development and clinical application of an immunofluorometric assay for intact parathyroid hormone,” Brazilian Journal of Medical and Biological Research, vol. 27, no. 10, pp. 2379–2382, 1994. View at Google Scholar · View at Scopus
  21. J. H. Brossard, M. Cloutier, L. Roy, R. Lepage, M. Gascon-Barré, and P. D'Amour, “Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 11, pp. 3923–3929, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Lepage, L. Roy, J. H. Brossard et al., “A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples,” Clinical Chemistry, vol. 44, no. 4, pp. 805–809, 1998. View at Google Scholar · View at Scopus
  23. I. S. Kunii and J. G. H. Vieira, “Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure,” Brazilian Journal of Medical and Biological Research, vol. 34, no. 12, pp. 1547–1550, 2001. View at Google Scholar · View at Scopus
  24. S. J. Silverberg, P. Gao, I. Brown, P. Logerfo, T. L. Cantor, and J. P. Bilezikian, “Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 10, pp. 4725–4730, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Boudou, F. Ibrahim, C. Cormier, A. Chabas, E. Sarfati, and J. C. Souberbielle, “Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6370–6372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Eastell, A. Arnold, M. L. Brandi et al., “Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 340–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Aloia, M. Feuerman, and J. K. Yeh, “Reference range for serum parathyroid hormone,” Endocrine Practice, vol. 12, no. 2, pp. 137–144, 2006. View at Google Scholar · View at Scopus
  28. L. Rejnmark, P. Vestergaard, L. Heickendorff, and L. Mosekilde, “Determinants of plasma PTH and their implication for defining a reference interval,” Clinical Endocrinology, vol. 74, no. 1, pp. 37–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. D. Quarles, B. Lobaugh, and G. Murphy, “Intact parathyroid hormoneover-estimates the presence and severity of parathyroid mediated osseous abnormalities in uremia,” Journal of Clinical Endocrinology and Metabolism, vol. 75, pp. 143–150, 1992. View at Google Scholar
  30. G. Coen, E. Bonucci, P. Ballanti et al., “PTH 1-84 and PTH “7-84” in the noninvasive diagnosis of renal bone disease,” American Journal of Kidney Diseases, vol. 40, no. 2, pp. 348–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. L. E. Mallette, “The parathyroid polyhormones: new concepts in the spectrum of peptide hormone action,” Endocrine Reviews, vol. 12, no. 2, pp. 110–117, 1991. View at Google Scholar · View at Scopus
  32. M. R. Rubin, S. J. Silverberg, P. D'Amour et al., “An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma,” Clinical Chemistry, vol. 53, no. 8, pp. 1470–1476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. V. M. Carvalho, “The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory,” Journal of Chromatography B, vol. 883-884, pp. 50–58, 2012. View at Google Scholar
  34. M. F. Lopez, T. Rezai, D. A. Sarracino et al., “Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants,” Clinical Chemistry, vol. 56, no. 2, pp. 281–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Kumar, D. R. Barnidge, L. S. Chen et al., “Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry,” Clinical Chemistry, vol. 56, no. 2, pp. 306–313, 2010. View at Publisher · View at Google Scholar · View at Scopus